针对自身免疫性疾病的宽容性树突细胞疗法的挑战:施用途径
María José Mansilla1,2, Catharien M U Hilkens3, Eva M Martínez-Cáceres1,2
1Division of Immunology, LCMN, Germans Trias i Pujol University Hospital and Research Institute, Campus Can Ruti, Badalona, Spain.
Immunotherapy advances
|August 7, 2023
概括
宽容性树突细胞 (tolDCs) 为MS,T1D和RA等自身免疫性疾病提供了安全有效的方法. 优化给药途径对于提高tolDC治疗疗效至关重要.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞疗法细胞疗法
- 自身免疫性疾病的治疗方法
背景情况:
- 宽容性树突细胞 (tolDCs) 调节自身免疫性疾病治疗的免疫反应.
- 在临床前模型和MS,T1D和RA的I期临床试验中,TolDC疗法显示出有前途.
- 目前的研究重点是优化tolDC治疗参数,特别是给药途径.
研究的目的:
- 审查关于多发性硬化,T1D和RA的tolDC治疗的临床前和临床数据.
- 评估tolDCs的各种管理途径.
- 确定最可行的,最安全和最有效的治疗途径.
主要方法:
- 对tolDC治疗的临床前研究和I期临床试验的审查.
- 分析使用成熟的载DCs进行癌症免疫治疗的数据.
- 包括体内细胞追踪实验数据.
主要成果:
- 在实验性自身免疫性疾病和人体试验中,TolDC治疗已经证明了安全性和有效性.
- 已经探索了多种管理路径 (IV,SC,IP,ID,IN,IA).
- 数据表明,优化给药途径是提高疗效的关键.
结论:
- 托尔DC疗法是对自身免疫性疾病的一种安全且耐受良好的策略.
- 选择给药途径显著影响tolDC治疗的有效性.
- 需要进一步的研究来确定最大限度地提高治疗效益的最佳途径.
更多相关视频
11:34A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14+ Monocytes
Published on: April 11, 2025
340
07:04Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation
Published on: September 16, 2018
10.1K
相关概念视频
01:40Cell-mediated Immune Responses
68.9K
Overview
68.9K
01:27Tumor Immunotherapy
557
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
557